logo

Il-Dong Pharmaceutical

2, Baumoe-Ro 27-Gil, Seocho-Gu, Seoul, 06752


Update Date : 2026-04-01
Company information
Related News

  • Ildong Pharmaceutical Co Ltd (IPC) is a pharmaceutical company that manufactures of pharmaceutical products. It manufactures and commercializes pharmaceuticals and pharmaceutical ingredients. The company offers finished drugs such as antibiotics, antifungal and antiviral products, antihistamine drugs, antineoplastic agents, vitamins, minerals and nutrients and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications.
  • Probiotics: Ildong Pharmaceutical is well-known for its expertise in probiotics. The company has developed a wide range of probiotic products for various health conditions. Central Nervous System (CNS) Drugs: Ildong has a strong focus on the development of CNS drugs, including treatments for neurological disorders. Anti-infective Agents: The company has a long history of developing and manufacturing anti-infective agents, such as antibiotics. Biosimilars: Ildong is actively involved in the development of biosimilars, which are highly similar copies of original biologic products. Formulation Development: Ildong has expertise in formulating various dosage forms to optimize drug delivery and improve patient compliance. Open Innovation: Ildong actively collaborates with academic institutions, research organizations, and other pharmaceutical companies to accelerate drug development and expand its product pipeline.
  • Public
  • Pharma, Investor, CDMO, Bio, Medical device
  • Code
    Pre-Clinical
    Undisclosed
    Solid tumor
    Code
    Phase I
    Venadaparib
    Solid tumor
Copyright ⓒ BQURA, Mediandshare 2024

Publisher-Editor : Wan Ju (Jay) Kim

Address : 919, 33, International Finance Road 6-gil, Yeongdeungpo-gu, Seoul, Korea

Tel : 82-10-9336-6304 / bqura.adm@gmail.com

Copyright ⓒ BQURA, Mediandshare 2024

BQURA